Table 1.
Characteristic | Overall (n = 7) |
---|---|
Mean age at surgery ± SD | 54.1 ± 6.9 |
Race, n (%) | |
White | 5 (71.4%) |
Black | 2 (28.6%) |
History of hypertension, n (%) | 2 (28.6%) |
History of diabetes, n (%) | 0 (0%) |
Smoking status, n (%) | |
Never smoker | 5 (71.4%) |
Former smoker | 2 (28.6%) |
Charlson age‐comorbidity index, n (%) | |
2 | 2 (28.6%) |
3 | 3 (42.9%) |
4 | 1 (14.3%) |
8 | 1 (14.3%) |
PSA (ng/ml) | |
Median (IQR) | 6.8 (4.4–7.9) |
Mean ± SD | 5.8 ± 2.7 |
Clinical stage, n (%) | |
cT1c | 5 (71.4%) |
cT2a | 2 (28.6%) |
Biopsy grade group, n (%) | |
1 | 1 (14.3%) |
2 | 3 (42.9%) |
3 | 2 (28.6%) |
4 | 1 (14.3%) |
Abbreviation: IQR, interquartile range; PSA, prostate‐specific antigen; SD, standard deviation.